MOR208 (formerly XmAb5574) is a potent anti-CD19 antibody with a proprietary modification to the Fc portion, that is being developed to treat B-cell malignancies. The open-label, multi-dose, single-arm,
Testim is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of testosterone. As per the agreement, GSK has been granted
The study concluded that iCALM is a novel inhaled therapeutic with a previously unexplored mechanism of action that can lead to better control of symptoms and lung function
Under the terms of the agreement, Xiangxue Pharma will acquire the rights to the development and commercialization of Kinex Pharmaceuticals’ KX02 for all oncology indications in greater China,
As per the alliance, the high-level cancer research technology and clinical experience of the National Cancer Center will be integrated with the advanced research and drug discovery capabilities
The new Period Vitamin will provide vitamins and minerals that are required for women’s health, as well as offer herbs to target specific premenstrual syndrome (PMS) symptoms. Period
In return, Marina will receive royalties from the sale of CRN-based oligonucleotide reagents as well as a robust supply of cGMP material for Marina and its partners’ pre-clinical,
The state government is formulating a new drug policy that will allow the state health department to procure these drugs for government hospitals, unlike earlier the department used
Actimmune, a synthesized version of interferon gamma – a naturally occurring protein believed to stimulate the immune system, is indicated for the treatment of two life-threatening congenital diseases:
Aushon’s microarray printing, novel assay design, astronomy-grade imaging and advanced analytics provide the sensitivity and reproducibility of single-plexed ELISA in a multiplexed format. The technology is expected to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.